84 related articles for article (PubMed ID: 2295703)
1. Characterization of biologically active, platelet-derived growth factor-like molecules produced by murine erythroid cells in vitro and in vivo.
Sytkowski AJ; O'Hara C; Vanasse G; Armstrong MJ; Kreczko S; Dainiak N
J Clin Invest; 1990 Jan; 85(1):40-6. PubMed ID: 2295703
[TBL] [Abstract][Full Text] [Related]
2. Regulated production of a pleiotropic cytokine-platelet-derived growth factor--by differentiating erythroid cells in vitro and in vivo.
Keutzer JC; Sytkowski AJ
Proc Natl Acad Sci U S A; 1995 May; 92(11):4967-71. PubMed ID: 7761433
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor promotes proliferation of erythropoietic progenitor cells in vitro.
Dainiak N; Davies G; Kalmanti M; Lawler J; Kulkarni V
J Clin Invest; 1983 May; 71(5):1206-14. PubMed ID: 6853708
[TBL] [Abstract][Full Text] [Related]
4. Growth factor production by human thyroid carcinoma cells: abundant expression of a platelet-derived growth factor-B-like protein by a human papillary carcinoma cell line.
Matsuo K; Tang SH; Sharifi B; Rubin SA; Schreck R; Fagin JA
J Clin Endocrinol Metab; 1993 Oct; 77(4):996-1004. PubMed ID: 8408476
[TBL] [Abstract][Full Text] [Related]
5. B-lymphocyte-derived burst-promoting activity is a pleiotropic erythroid colony-stimulating factor, E-CSF.
Feldman L; Frazier JG; Sytkowski AJ
Exp Hematol; 1992 Nov; 20(10):1223-8. PubMed ID: 1426102
[TBL] [Abstract][Full Text] [Related]
6. Acetylated lipoproteins impair erythroid growth factor release from endothelial cells.
Dainiak N; Warren HB; Kreczko S; Riordan MA; Feldman L; Lawler J; Cohen AM; Davies PF
J Clin Invest; 1988 Mar; 81(3):834-43. PubMed ID: 3278006
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor enhances in vitro erythropoiesis via stimulation of mesenchymal cells.
Delwiche F; Raines E; Powell J; Ross R; Adamson J
J Clin Invest; 1985 Jul; 76(1):137-42. PubMed ID: 4019772
[TBL] [Abstract][Full Text] [Related]
8. Rat Leydig cells bind platelet-derived growth factor through specific receptors and produce platelet-derived growth factor-like molecules.
Gnessi L; Emidi A; Farini D; Scarpa S; Modesti A; Ciampani T; Silvestroni L; Spera G
Endocrinology; 1992 Apr; 130(4):2219-24. PubMed ID: 1312451
[TBL] [Abstract][Full Text] [Related]
9. A sensitive new bioassay for erythroid colony-stimulating factor.
Feldman L; Davis KL; Feeley DM; Sytkowski AJ
Exp Hematol; 1993 Dec; 21(13):1657-62. PubMed ID: 8243567
[TBL] [Abstract][Full Text] [Related]
10. Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development.
Sawada K; Krantz SB; Dessypris EN; Koury ST; Sawyer ST
J Clin Invest; 1989 May; 83(5):1701-9. PubMed ID: 2651478
[TBL] [Abstract][Full Text] [Related]
11. Erythroid-potentiating activity: characterization and target cells.
Gauwerky CE; Lusis AJ; Golde DW
Exp Hematol; 1980; 8 Suppl 8():117-27. PubMed ID: 6984393
[TBL] [Abstract][Full Text] [Related]
12. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
[TBL] [Abstract][Full Text] [Related]
13. Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: possible molecular mechanism of drug-induced gingival hyperplasia.
Iacopino AM; Doxey D; Cutler CW; Nares S; Stoever K; Fojt J; Gonzales A; Dill RE
J Periodontol; 1997 Jan; 68(1):73-83. PubMed ID: 9029455
[TBL] [Abstract][Full Text] [Related]
14. Thymus-conditioned medium influences in vitro colony formation by hematopoietic progenitor cells.
Meagher RC; Spivak JL; Sensenbrenner LL; Sharkis SJ
Stem Cells (1981); 1982; 2(6):321-34. PubMed ID: 6985272
[TBL] [Abstract][Full Text] [Related]
15. Autocrine growth stimulation of human meningioma cells by platelet-derived growth factor.
Todo T; Adams EF; Fahlbusch R; Dingermann T; Werner H
J Neurosurg; 1996 May; 84(5):852-8; discussion 858-9. PubMed ID: 8622161
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor (PDGF) activates primitive hematopoietic precursors (pre-CFCmulti) by up-regulating IL-1 in PDGF receptor-expressing macrophages.
Yan XQ; Brady G; Iscove NN
J Immunol; 1993 Mar; 150(6):2440-8. PubMed ID: 8450221
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
[TBL] [Abstract][Full Text] [Related]
18. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes.
Greenberger JS; Krensky AM; Messner H; Burakoff SJ; Wandl U; Sakakeeny MA
Exp Hematol; 1984 Oct; 12(9):720-7. PubMed ID: 6333354
[TBL] [Abstract][Full Text] [Related]
19. New procedure for purification of human platelet-derived growth factor.
Czyrski JA; Narczewska B; Inglot AD
Arch Immunol Ther Exp (Warsz); 1984; 32(5):589-98. PubMed ID: 6534324
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of erythroid differentiation of mouse erythroleukemia cells by a macrophage product(s).
Sassa S; Wolpe S; Cerami A
Blood Cells; 1987; 13(1-2):161-9. PubMed ID: 3478107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
